Involving 316 commonly used medications! Bidding for the follow-up procurement of the 1st to 8th batch of nationally centralized drug purchases.

On February 10th, the reporter learned from the National Medical Insurance Administration that the new round of continued procurement of 1st to 8th batches of nationally centralized procurement drugs has resulted in tentative selection results, involving 316 commonly used drugs. 4163 products from 1020 companies have been granted tentative selection qualifications. The drugs in this round of continued procurement cover 26 treatment areas including anti-infection, anti-tumor, lowering blood sugar, lowering blood pressure, lowering blood lipids, nervous system, respiratory system, digestive system, etc.